Trial design challenges when combining medication and parent training in children with pervasive developmental disorders

Journal of Autism and Developmental Disorders

Volumn 39, Issue 5, 2009, Pages 720-729

  Scahill, Lawrence ^a   Aman, Michael G ^b   McDougle, Christopher J ^c   Arnold, L Eugene ^b   McCracken, James T ^d   Handen, Benjamin ^e   Johnson, Cynthia ^e   Dziura, James ^a   Butter, Eric ^b   Sukhodolsky, Denis ^a   Swiezy, Naomi ^c   Mulick, James ^b   Stigler, Kimberly ^c   Bearss, Karen ^a   Ritz, Louise ^f   Wagner, Ann ^f   Vitiello, Benedetto ^f  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c INDIANA UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF PITTSBURGH   (United States)

^f NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Autism; Behavior therapy; Clinical trial methodology; Risperidone

Indexed keywords

ARIPIPRAZOLE; RISPERIDONE;

ADAPTIVE BEHAVIOR; ADOLESCENT; AGGRESSION; ANGER; ARTICLE; AUTISM; AUTOMUTILATION; BEDTIME DOSAGE; BEHAVIOR THERAPY; CHILD; CHILD BEHAVIOR; CHILD PARENT RELATION; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PARENT; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELAPSE; SCHOOL CHILD; TRAINING; TREATMENT OUTCOME;

ADOLESCENT; AGGRESSION; BEHAVIOR THERAPY; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; COMBINED MODALITY THERAPY; DOPAMINE ANTAGONISTS; FEMALE; HUMANS; MALE; OUTPATIENTS; PARENT-CHILD RELATIONS; PARENTS; PATIENT COMPLIANCE; PERSONALITY ASSESSMENT; PSYCHIATRIC STATUS RATING SCALES; RISPERIDONE; SELF-INJURIOUS BEHAVIOR; TREATMENT OUTCOME;

EID: 67349249372     PISSN: 01623257     EISSN: 15733432     Source Type: Journal    
DOI: 10.1007/s10803-008-0675-2     Document Type: Article

References (38)

1. H Abikoff L Hechtman RG Klein G Weiss K Fleiss J Etcovitch L Cousins B Greenfield D Martin S Pollack 2004 Symptomatic improvement in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment Journal of the American Academy of Child and Adolescent Psychiatry 43 802 811
2. MG Aman NN Singh AW Stewart CJ Field 1985 The Aberrant Behavior Checklist: A behavior rating scale for the assessment of treatment effects American Journal of Mental Deficiency 89 485 491
3. MG Aman NN Singh SH Turbott 1987 Reliability of the Aberrant Behavior Checklist and the effect of variations in instructions American Journal of Mental Deficiency 92 237 240
4. Barkley, R. A., & Murphy, K. R. (1998). Attention deficit hyperactivity disorder: A clinical workbook (2nd ed.). New York: Guilford.
5. Borenstein, M., Rothman, H., & Cohen, J. (1997). Power and precision program. New Jersey: Erlbaum.
6. EC Brown MG Aman SM Havercamp 2002 Factor analysis and norms for parent ratings on the Aberrant Behavior Checklist-community for young people in special education Research in Developmental Disabilities 23 45 60
7. M Campbell JL Armenteros RP Malone PB Adams ZW Eisenberg JE Overall 1997 Neuroleptic-related dyskinesias in autistic children: a prospective, longitudinal study Journal of the American Academy of Child and Adolescent Psychiatry 36 835 843
8. AS Carter FR Volkmar SS Sparrow JJ Wang C Lord G Dawson E Fombonne K Loveland G Mesibov E Schopler 1998 The Vineland Adaptive Behavior Scales: Supplementary norms for individuals with autism Journal of Autism and Developmental Disorders 28 287 302
9. National Research Council. (2001). Educating children with autism. Washington, DC: National Academies Press.
10. E Fombonne 2003 The prevalence of autism Journal of the American Medical Association 289 87 89
11. KD Gadow CJ Devincent J Pomeroy A Azizian 2005 Comparison of DSM-IV symptoms in elementary school-age children with PDD versus clinic and community samples Autism 9 4 392 415
12. RD Gibbons D Hedeker I Elkin C Waternaux HC Kraemer JB Greenhouse MT Shea SD Imber SM Sotsky JT Watkins 1993 Some conceptual and statistical issues in analysis of longitudinal psychiatric data. Application to the NIMH treatment of depression collaborative research program dataset Archives of General Psychiatry 50 739 750
13. Guy, W. (1976). ECDEU assessment manual for psychopharmacology. Washington, DC: DHEW, NIMH.
14. E Hollander A Phillips W Chaplin K Zagursky S Novotny S Wasserman R Iyengar 2005 A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism Neuropsychopharmacology 30 582 589
15. CR Johnson BL Handen E Butter A Wagner J Mulick DG Sukhodolsky S Williams NA Swiezy LE Arnold MG Aman L Scahill KA Stigler CJ McDougle B Vitiello T Smith 2007 Development of a parent training program for children with pervasive developmental disorders Behavioral Interventions 22 201 221
16. JM Kane WH Carson AR Saha RD McQuade GG Ingenito DL Zimbroff MW Ali 2002 Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder Journal of Clinical Psychiatry 63 763 771
17. Kazdin, A., & Weisz, J. R. (Eds.). (2003). Evidence-based psychotherapies for children and adolescents. New York: Guilford Press.
18. D Kraijer 2000 Review of adaptive behavior studies in mentally retarded persons with autism/pervasive developmental disorder Journal of Autism and Developmental Disorders 30 39 47
19. C Lord A Wagner S Rogers P Szatmari M Aman T Charman G Dawson VM Durand L Grossman D Guthrie S Harris C Kasari L Marcus S Murphy S Odom A Pickles L Scahill E Shaw B Siegel M Sigman W Stone T Smith P Yoder 2005 Challenges in evaluating psychosocial interventions for autistic spectrum disorders Journal of Autism and Developmental Disorders 35 695 708 (discussion 709-711)
20. OI Lovaas 1987 Behavioral treatment and normal educational and intellectual functioning in young autistic children Journal of Consulting and Clinical Psychology 55 3 9
21. CJ McDougle L Scahill MG Aman JT McCracken E Tierney M Davies LE Arnold DJ Posey A Martin JK Ghuman B Shah SZ Chuang NB Swiezy NM Gonzalez J Hollway K Koenig JJ McGough L Ritz B Vitiello 2005 Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology American Journal of Psychiatry 162 1142 1148
22. CJ McDougle KA Stigler CA Erickson DJ Posey 2008 Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders Journal of Clinical Psychiatry 69 Suppl 4 15 20
23. MTA Cooperative Group 1999 Multimodal treatment study of children with ADHD: A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder Archives of General Psychiatry 56 1073 1086
24. Pediatric OCD Treatment Study (POTS) Team 2004 Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: The Pediatric OCD Treatment Study (POTS) randomized controlled trial Journal of the American Medical Association 292 1969 1976
25. Research Units on Pediatric Psychopharmacology Autism Network 2002 Risperidone in children with autism for serious behavioral problems New England Journal of Medicine 347 314 321
26. Research Units on Pediatric Psychopharmacology Autism Network 2005 Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity Archives of General Psychiatry 62 1266 1274
27. Research Units on Pediatric Psychopharmacology Autism Network 2005 Risperidone treatment of autistic disorder: Longer term benefits and blinded discontinuation after six months American Journal of Psychiatry 162 1361 1369
28. Research Units on Pediatric Psychopharmacology Autism Network 2007 Parent training for children with pervasive developmental disorders: A multi-site feasibility trial Behavioral Interventions 22 179 199
29. Scahill, L., & Martin, A. (2005). Psychopharmacology. In F. Volkmar, A. Klin, & R. Paul (Eds.), Handbook of autism and pervasive developmental disorders (3rd ed., pp. 1102-1117). New York: Wiley.
30. L Scahill M Solanto J McGuire 2008 The science and ethics of placebo in pediatric psychopharmacology Ethics and Behavior 18 266 285
31. L Schreibman 2000 Intensive behavioral/psychoeducational treatments for autism: Research needs and future directions Journal of Autism and Developmental Disorders 30 373 378
32. S Shea A Turgay A Carroll M Schulz H Orlik I Smith F Dunbar 2004 Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders Pediatrics 114 5 634 641
33. PE Shrout N Bolger 2002 Mediation in experimental and nonexperimental studies: new procedures and recommendations Psychological Methods 7 422 445
34. T Smith GA Buch TE Gamby 2000 Parent-directed, intensive early intervention for children with pervasive developmental disorder Research in Developmental Disabilities 21 297 309
35. T Smith L Scahill G Dawson D Guthrie C Lord S Odom S Rogers A Wagner 2007 Designing research studies on psychosocial interventions in autism Journal of Autism and Developmental Disorders 37 354 366
36. Sparrow, S. S., Balla, D. A., & Cicchetti, D. V. (1984). Vineland Adaptive Behavior scales: Survey form manual. Circle Pines: American Guidance Service.
37. Treatment for Adolescents with Depression Study (TADS) Team 2004 Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents with Depression Study (TADS) randomized controlled trial Journal of the American Medical Association 292 807 820
38. SK Williams L Scahill B Vitiello MG Aman LE Arnold CJ McDougle JT McCracken E Tierney L Ritz DJ Posey NB Swiezy J Hollway P Cronin J Ghuman C Wheeler D Cicchetti S Sparrow 2006 Risperidone and adaptive behavior in children with autism Journal of the American Academy of Child and Adolescent Psychiatry 45 431 439